ProfileGDS4718 / 1555467_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 64% 66% 66% 62% 64% 70% 65% 62% 62% 65% 62% 69% 67% 63% 65% 63% 68% 65% 59% 67% 67% 62% 67% 62% 69% 68% 58% 65% 60% 59% 66% 64% 71% 60% 65% 62% 64% 63% 69% 67% 60% 58% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5919466
GSM549102patient 115, normal, homogenized [OPG study]6.4150364
GSM549104patient 119, normal, homogenized [OPG study]6.6227266
GSM549108patient 138, normal, homogenized [OPG study]6.554566
GSM549119patient 077, normal, homogenized [OPG study]6.2327562
GSM549133patient 032, cancer, homogenized [OPG study]6.4263564
GSM549139patient 042, cancer, homogenized [OPG study]6.9024470
GSM549099patient 107, normal, homogenized [OPG study]6.4662865
GSM549109patient 139, normal, homogenized [OPG study]6.2600162
GSM549110patient 046, normal, homogenized [OPG study]6.2330962
GSM549114patient 063, normal, homogenized [OPG study]6.4337565
GSM549122patient 082, normal, homogenized [OPG study]6.2823362
GSM549134patient 033, cancer, homogenized [OPG study]6.7988469
GSM549136patient 036, cancer, homogenized [OPG study]6.66567
GSM549140patient 044, cancer, homogenized [OPG study]6.3535763
GSM549111patient 047, normal, homogenized [OPG study]6.4954465
GSM549113patient 057, normal, homogenized [OPG study]6.3404663
GSM549132patient 031, cancer, homogenized [OPG study]6.6908368
GSM549137patient 038, cancer, homogenized [OPG study]6.4721565
GSM549142patient 047, cancer, homogenized [OPG study]6.1455559
GSM549100patient 110, normal, homogenized [OPG study]6.5617967
GSM549107patient 135, normal, homogenized [OPG study]6.5918567
GSM549115patient 068, normal, homogenized [OPG study]6.2538262
GSM549116patient 072, normal, homogenized [OPG study]6.646967
GSM549120patient 078, normal, homogenized [OPG study]6.2960662
GSM549131patient 030, cancer, homogenized [OPG study]6.823369
GSM549118patient 074, normal, homogenized [OPG study]6.7280468
GSM549129patient 027, cancer, homogenized [OPG study]6.0455158
GSM549123patient 088, normal, homogenized [OPG study]6.5093465
GSM549124patient 006, cancer, homogenized [OPG study]6.1166760
GSM549126patient 015, cancer, homogenized [OPG study]6.046659
GSM549128patient 025, cancer, homogenized [OPG study]6.6019666
GSM549103patient 117, normal, homogenized [OPG study]6.3716564
GSM549117patient 073, normal, homogenized [OPG study]6.9041871
GSM549138patient 041, cancer, homogenized [OPG study]6.1241660
GSM549141patient 045, cancer, homogenized [OPG study]6.5344165
GSM549130patient 028, cancer, homogenized [OPG study]6.2635562
GSM549101patient 111, normal, homogenized [OPG study]6.4281164
GSM549105patient 128, normal, homogenized [OPG study]6.3712363
GSM549106patient 134, normal, homogenized [OPG study]6.8654569
GSM549112patient 048, normal, homogenized [OPG study]6.6128967
GSM549125patient 011, cancer, homogenized [OPG study]6.1039460
GSM549127patient 024, cancer, homogenized [OPG study]6.0550758
GSM549135patient 035, cancer, homogenized [OPG study]6.7039467